title: Mechanisms of extrahepatic vasodilation in portal hypertension.
abstract: In liver cirrhosis, abnormal persistent extrahepatic vasodilation leads to hyperdynamic circulatory dysfunction which essentially contributes to portal hypertension. Since portal hypertension is a major factor in the development of complications in cirrhosis, the mechanisms underlying this vasodilation are of paramount interest. Extensive studies performed in cirrhotic patients and animals revealed that this vasodilation is associated on the one hand with enhanced formation of vasodilators, and on the other hand with vascular hyporesponsiveness to vasoconstrictors. The latter phenomenon has been termed "vascular hypocontractility". It is caused by a combination of different mechanisms and factors described in this review.
authors.affiliation: Department of Internal Medicine I, University of Bonn, Sigmund-Freud-Str. 25, D-53105 Bonn, Germany. Martin.Hennenberg@ukb.uni-bonn.de
authors.forename: M
authors.initials: M
authors.lastname: Hennenberg
authors.forename: J
authors.initials: J
authors.lastname: Trebicka
authors.forename: T
authors.initials: T
authors.lastname: Sauerbruch
authors.forename: J
authors.initials: J
authors.lastname: Heller
mesh_terms: D063385:Cannabinoid Receptor Modulators / Q000502:physiology; D006801:Humans; D006975:Hypertension, Portal / Q000209:etiology* / Q000503:physiopathology*; D008103:Liver Cirrhosis / Q000150:complications* / Q000503:physiopathology; D009131:Muscle, Smooth, Vascular / Q000503:physiopathology; D009569:Nitric Oxide / Q000502:physiology; D015398:Signal Transduction; D013152:Splanchnic Circulation; D014664:Vasodilation
chemical_list: D063385:Cannabinoid Receptor Modulators; D009569:Nitric Oxide